"The Cerebras CS-2 is a critical component that allows GSK to train language models using biological datasets at a scale and size previously unattainable.

 

These foundational models form the basis of many of our AI systems and play a vital role in the discovery of transformational medicines."

Kim Branson

SVP Global Head of AI and ML @ GSK

See how GSK is using the Cerebras System

GSK and Cerebras are Advancing the State of the Art in AI for Drug Discovery

GSK published findings: EBERT models for epigonomic research were 160 times faster on the CS-1 than on a GPU

How AI Is Aiming at the Bad Math of Drug Development

Unconventional collaborations between biopharma and tech are starting to take off

Unconventional collaborations between biopharma and tech are starting to take off